Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Change in Accured Expenses (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Change in Accured Expenses for 16 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 109.67% to $2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Dec 2025, up 160.46% year-over-year, with the annual reading at $6.2 million for FY2025, 160.46% up from the prior year.
  • Change in Accured Expenses hit $2.1 million in Q4 2025 for Ironwood Pharmaceuticals, up from $249000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $17.6 million in Q2 2023 to a low of -$21.7 million in Q4 2024.
  • Historically, Change in Accured Expenses has averaged -$53050.0 across 5 years, with a median of $477000.0 in 2023.
  • Biggest YoY gain for Change in Accured Expenses was 4095.5% in 2022; the steepest drop was 9682.99% in 2022.
  • Year by year, Change in Accured Expenses stood at -$1.1 million in 2021, then plummeted by 82.38% to -$2.0 million in 2022, then surged by 541.58% to $8.9 million in 2023, then plummeted by 344.43% to -$21.7 million in 2024, then skyrocketed by 109.67% to $2.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for IRWD at $2.1 million in Q4 2025, $249000.0 in Q3 2025, and -$5.8 million in Q2 2025.